TGFB1 and neoplasm: N2 TANs produce immunosuppressive cytokines such as IL-10 and transforming growth factor-beta (TGF-β), which inhibit the activity of cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells, allowing tumor cells to evade immune surveillance.